"I tried it for a few weeks, it did nothing."

This comment often comes up when discussing joint supplements. However, a few weeks are rarely enough to properly evaluate this type of product.

A dietary supplement does not work like a classic anti-inflammatory. Its effectiveness is not judged in a few days, but over time and with adherence.

Why timing matters so much

A non-steroidal anti-inflammatory acts quickly because it blocks an enzymatic pathway involved in inflammation and pain.

A nutraceutical works differently.

Depending on the active ingredient used, the effect can depend on a progressive modification of cell membrane composition, modulation of inflammation, structural support, or a slower immunological mechanism.

The onset of action therefore directly depends on how these ingredients work in the body.

Useful benchmarks in the literature

For EPA/DHA omega-3s, Mehler's study shows visible biological changes at 42 days and significant clinical improvement at 84 days.

So, we're looking at an evaluation over several weeks, not a few days.

For green-lipped mussel, Hielm-Björkman's trial ran for 8 weeks, with repeated evaluations. Here too, improvement is progressive.

For UC-II®, D’Altilio's study reports improvements starting at 30 days, with an effect that continues to evolve up to 120 days.

Clinical studies on CBD in dogs follow the same logic: results are evaluated over several weeks to several months, not after a few doses.

The right time to evaluate

In practice, a period of 8 to 12 weeks of daily administration constitutes a reasonable timeframe to evaluate a joint supplement in dogs.

This timeframe is not an absolute rule, but it corresponds to the evaluation durations found in a large part of the available studies.

Below this, the conclusion is often premature.

How to objectify the evolution

Improvements are often progressive and subtle.

A dog might get up a little more easily, hesitate less before climbing a step, recover a little better after an outing, or stiffen less quickly after a period of rest.

These changes can go unnoticed if one relies only on a general impression.

To track progress, it is useful to:

• film the dog regularly;
• note its ease in getting up;
• observe cold starts;
• monitor stairs, jumps, walks, and recovery;
• keep a small mobility diary;
• rely, when possible, on veterinary advice or validated scores.

A supplement can provide benefits without producing a spectacular before/after.

Without simple monitoring, many owners too quickly conclude that there is no effect.

When to conclude no effect

After 12 properly conducted weeks, at the correct dose, frequency, and with a reliable product, the absence of improvement becomes a result in itself.

It may then be useful to re-evaluate the chosen product, the diagnosis, the pain level, weight management, physical activity, or the dog's overall care.

A supplement should also not be continued indefinitely if it provides no observable benefit.

________________________________________________________________________________________________

Sources

1. Mehler S.J. et al. (2016). A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. First biological markers at day 42, clinical improvement at day 84.
2. Hielm-Björkman A. et al. (2007/2009 PMC). Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus). 8-week study with progressive improvement.
3. D’Altilio M. et al. (2007). Therapeutic Efficacy and Safety of Undenatured Type II Collagen Singly or in Combination with Glucosamine and Chondroitin in Arthritic Dogs. First effects at 30 days, peak later up to 120 days.
4. McGrath/Rozental and other CBD studies: evaluations over several weeks to several months, not a few days.